Clarivate (CLVT) Stock Forecast, Price Target & Predictions
CLVT Stock Forecast
Clarivate stock forecast is as follows: an average price target of $14.33 (represents a 118.11% upside from CLVT’s last price of $6.57) and a rating consensus of 'Buy', based on 3 wall street analysts offering a 1-year stock forecast.
CLVT Price Target
The average price target for Clarivate (CLVT) is $14.33 based on 1-year price targets from 3 Wall Street analysts in the past 3 months, with a price target range of $20.00 to $11.00. This represents a potential 118.11% upside from CLVT's last price of $6.57.
CLVT Analyst Ratings
According to 3 Wall Street analysts, Clarivate's rating consensus is 'Buy'. The analyst rating breakdown for CLVT stock is 0 'Strong Buy' (0.00%), 1 'Buy' (33.33%), 1 'Hold' (33.33%), 1 'Sell' (33.33%), and 0 'Strong Sell' (0.00%).
Clarivate Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Jun 13, 2023 | Owen Lau | Oppenheimer | $11.00 | $8.98 | 22.43% | 67.43% |
| Feb 06, 2023 | - | Morgan Stanley | $12.00 | $11.19 | 7.24% | 82.65% |
| Apr 19, 2022 | - | Goldman Sachs | $20.00 | $17.07 | 17.16% | 204.41% |
The latest Clarivate stock forecast, released on Jun 13, 2023 by Owen Lau from Oppenheimer, set a price target of $11.00, which represents a 22.43% increase from the stock price at the time of the forecast ($8.98), and a 67.43% increase from CLVT last price ($6.57).
Clarivate Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | - |
| Avg Price Target | - | - | - |
| Last Closing Price | $6.57 | $6.57 | $6.57 |
| Upside/Downside | -100.00% | -100.00% | -100.00% |
In the current month, the average price target of Clarivate stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Clarivate's last price of $6.57. This month's average price target is down NaN% compared to last quarter, and down NaN% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Sep 08, 2023 | Barclays | - | Underweight | Downgrade |
| Jun 13, 2023 | Oppenheimer | - | Outperform | Initialise |
| Feb 06, 2023 | Morgan Stanley | - | Equal-Weight | Downgrade |
Clarivate's last stock rating was published by Barclays on Sep 08, 2023. The company Downgrade its CLVT rating from "null" to "Underweight".
Clarivate Financial Forecast
Clarivate Revenue Forecast
| Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $683.70M | - | $668.80M | $629.10M | $675.30M | $635.70M | $560.70M | $442.12M | $445.64M | $428.43M | $455.60M | $284.36M |
| Avg Forecast | $751.00M | $698.60M | $712.40M | $659.30M | $722.10M | $671.70M | $685.00M | $634.00M | $705.45M | $658.23M | $665.56M | $629.74M | $691.98M | $641.87M | $651.94M | $614.85M | $684.59M | $631.45M | $673.10M | $622.64M | $650.04M | $643.79M | $560.10M | $447.12M | $435.24M | $417.08M | $472.26M | $296.85M |
| High Forecast | $760.67M | $707.59M | $721.42M | $667.65M | $731.25M | $680.21M | $693.68M | $642.03M | $714.39M | $666.56M | $673.99M | $637.72M | $700.74M | $650.12M | $660.20M | $622.64M | $692.76M | $639.45M | $681.62M | $630.52M | $658.28M | $651.95M | $565.77M | $451.65M | $439.64M | $421.30M | $477.05M | $299.86M |
| Low Forecast | $745.20M | $693.20M | $707.77M | $655.02M | $717.41M | $667.34M | $680.55M | $629.88M | $700.87M | $653.95M | $661.24M | $625.65M | $687.48M | $635.98M | $647.70M | $610.85M | $670.60M | $627.35M | $668.73M | $618.59M | $645.82M | $639.61M | $554.21M | $442.42M | $430.67M | $412.70M | $467.30M | $293.74M |
| # Analysts | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 5 | 4 | 4 | 7 | 5 | 6 | 3 | 2 | 2 | 6 | 4 | 6 | 4 | 6 | 4 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.00% | - | 0.99% | 1.01% | 1.04% | 0.99% | 1.00% | 0.99% | 1.02% | 1.03% | 0.96% | 0.96% |
Clarivate's average Quarter revenue forecast for Mar 24 based on 4 analysts is $614.85M, with a low forecast of $610.85M, and a high forecast of $622.64M. CLVT's average Quarter revenue forecast represents a -10.07% decrease compared to the company's last Quarter revenue of $683.70M (Dec 23).
Clarivate EBITDA Forecast
| Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 5 | 4 | 4 | 7 | 5 | 6 | 3 | 2 | 2 | 6 | 4 | 6 | 4 | 6 | 4 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $-625.00M | - | $237.20M | $236.60M | $517.60M | $239.10M | $-111.26M | $222.77M | $97.40M | $148.66M | $156.48M | $55.95M |
| Avg Forecast | $291.83M | $271.47M | $276.83M | $256.20M | $280.60M | $261.02M | $266.19M | $246.37M | $274.13M | $255.78M | $258.63M | $244.71M | $268.90M | $249.43M | $253.34M | $518.47M | $266.03M | $245.38M | $261.56M | $409.86M | $252.60M | $263.01M | $217.65M | $207.92M | $97.40M | $137.23M | $110.46M | $115.36M |
| High Forecast | $295.59M | $274.97M | $280.34M | $259.44M | $284.16M | $264.32M | $269.56M | $249.49M | $277.61M | $259.02M | $261.91M | $247.81M | $272.30M | $252.63M | $256.55M | $622.17M | $269.20M | $248.48M | $264.88M | $491.83M | $255.80M | $315.62M | $219.85M | $249.50M | $116.88M | $164.67M | $132.55M | $116.52M |
| Low Forecast | $289.58M | $269.37M | $275.04M | $254.54M | $278.78M | $259.32M | $264.46M | $244.77M | $272.35M | $254.12M | $256.95M | $243.12M | $267.15M | $247.14M | $251.69M | $414.78M | $260.59M | $243.78M | $259.86M | $327.89M | $250.96M | $210.41M | $215.36M | $166.33M | $77.92M | $109.78M | $88.37M | $114.14M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -2.35% | - | 0.91% | 0.58% | 2.05% | 0.91% | -0.51% | 1.07% | 1.00% | 1.08% | 1.42% | 0.49% |
5 analysts predict CLVT's average Quarter EBITDA for Sep 23 to be $245.38M, with a high of $248.48M and a low of $243.78M. This is 3.45% upper than Clarivate's previous annual EBITDA (Jun 23) of $237.20M.
Clarivate Net Income Forecast
| Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 5 | 4 | 4 | 7 | 5 | 6 | 3 | 2 | 2 | 6 | 4 | 6 | 4 | 6 | 4 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $-863.00M | - | $-123.10M | $43.50M | $323.40M | $-4.42B | $-111.35M | $23.31M | $-82.21M | $-23.95M | $6.42M | $-37.23M |
| Avg Forecast | $198.82M | $171.40M | $171.40M | $123.41M | $171.40M | $150.83M | $150.83M | $109.70M | $159.97M | $139.40M | $141.03M | $103.82M | $148.26M | $128.55M | $124.26M | $67.74M | $144.45M | $125.68M | $132.53M | $53.55M | $117.88M | $27.52M | $140.45M | $21.76M | $-82.21M | $-22.11M | $4.53M | $100.58M |
| High Forecast | $202.15M | $174.27M | $174.22M | $125.44M | $174.22M | $153.31M | $153.31M | $111.50M | $162.60M | $141.70M | $143.36M | $105.53M | $150.70M | $130.67M | $126.30M | $81.29M | $146.83M | $127.75M | $134.71M | $64.26M | $119.82M | $33.03M | $142.30M | $26.11M | $-65.77M | $-17.69M | $5.43M | $101.90M |
| Low Forecast | $196.83M | $169.68M | $169.95M | $122.37M | $169.95M | $149.56M | $149.56M | $108.77M | $158.62M | $138.22M | $139.84M | $102.94M | $147.01M | $115.02M | $123.21M | $54.19M | $130.69M | $124.61M | $131.42M | $42.84M | $116.88M | $22.02M | $138.54M | $17.41M | $-98.65M | $-26.53M | $3.62M | $99.21M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -5.97% | - | -0.93% | 0.81% | 2.74% | -160.43% | -0.79% | 1.07% | 1.00% | 1.08% | 1.42% | -0.37% |
Clarivate's average Quarter net income forecast for Jun 23 is $132.53M, with a range of $131.42M to $134.71M. CLVT's average Quarter net income forecast represents a 204.67% increase compared to the company's last Quarter net income of $43.50M (Mar 23).
Clarivate SG&A Forecast
| Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 5 | 4 | 4 | 7 | 5 | 6 | 3 | 2 | 2 | 6 | 4 | 6 | 4 | 6 | 4 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $180.40M | - | $192.90M | $194.80M | $180.60M | $169.50M | $-184.14M | $141.22M | $149.81M | $111.34M | $255.89M | $98.11M |
| Avg Forecast | $242.48M | $225.56M | $230.02M | $212.87M | $233.15M | $216.88M | $221.17M | $204.70M | $227.77M | $212.52M | $214.89M | $203.33M | $223.42M | $207.24M | $210.50M | $258.30M | $221.04M | $203.88M | $217.33M | $204.19M | $209.88M | $166.73M | $180.84M | $131.80M | $149.81M | $102.78M | $180.63M | $95.85M |
| High Forecast | $245.60M | $228.46M | $232.93M | $215.57M | $236.10M | $219.62M | $223.97M | $207.30M | $230.66M | $215.22M | $217.61M | $205.90M | $226.25M | $209.91M | $213.16M | $309.96M | $223.67M | $206.46M | $220.08M | $245.03M | $212.54M | $200.08M | $182.67M | $158.17M | $179.78M | $123.34M | $216.75M | $96.82M |
| Low Forecast | $240.61M | $223.82M | $228.52M | $211.49M | $231.63M | $215.47M | $219.73M | $203.37M | $226.29M | $211.14M | $213.50M | $202.01M | $221.97M | $205.34M | $209.13M | $206.64M | $216.52M | $202.55M | $215.92M | $163.35M | $208.52M | $133.39M | $178.94M | $105.44M | $119.85M | $82.22M | $144.50M | $94.84M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.82% | - | 0.89% | 0.95% | 0.86% | 1.02% | -1.02% | 1.07% | 1.00% | 1.08% | 1.42% | 1.02% |
Clarivate's average Quarter SG&A projection for Mar 24 is $258.30M, based on 4 Wall Street analysts, with a range of $206.64M to $309.96M. The forecast indicates a 43.18% rise compared to CLVT last annual SG&A of $180.40M (Dec 23).
Clarivate EPS Forecast
| Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 5 | 4 | 4 | 7 | 5 | 6 | 3 | 2 | 2 | 6 | 4 | 6 | 4 | 6 | 4 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $-1.30 | - | $-0.18 | $0.04 | $0.45 | $-6.56 | $-0.17 | $0.01 | $-0.13 | $-0.09 | $0.01 | $-0.10 |
| Avg Forecast | $0.29 | $0.25 | $0.25 | $0.18 | $0.25 | $0.22 | $0.22 | $0.16 | $0.23 | $0.20 | $0.21 | $0.15 | $0.22 | $0.19 | $0.18 | $0.14 | $0.21 | $0.18 | $0.19 | $0.15 | $0.17 | $0.17 | $0.21 | $0.15 | $0.17 | $0.12 | $0.17 | $0.15 |
| High Forecast | $0.29 | $0.25 | $0.25 | $0.18 | $0.25 | $0.22 | $0.22 | $0.16 | $0.24 | $0.21 | $0.21 | $0.15 | $0.22 | $0.19 | $0.18 | $0.14 | $0.21 | $0.19 | $0.20 | $0.16 | $0.17 | $0.18 | $0.21 | $0.16 | $0.17 | $0.12 | $0.17 | $0.15 |
| Low Forecast | $0.29 | $0.25 | $0.25 | $0.18 | $0.25 | $0.22 | $0.22 | $0.16 | $0.23 | $0.20 | $0.20 | $0.15 | $0.21 | $0.17 | $0.18 | $0.14 | $0.19 | $0.18 | $0.19 | $0.15 | $0.17 | $0.17 | $0.21 | $0.15 | $0.17 | $0.12 | $0.16 | $0.15 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -6.17% | - | -0.93% | 0.26% | 2.62% | -37.83% | -0.80% | 0.06% | -0.76% | -0.75% | 0.06% | -0.66% |
According to 6 Wall Street analysts, Clarivate's projected average Quarter EPS for Jun 23 is $0.19, with a low estimate of $0.19 and a high estimate of $0.20. This represents a 383.27% increase compared to CLVT previous annual EPS of $0.04 (Mar 23).
Clarivate Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| GDS | GDS | $16.12 | $51.91 | 222.02% | Buy |
| VNET | VNET Group | $2.87 | $6.73 | 134.49% | Buy |
| CLVT | Clarivate | $6.57 | $14.33 | 118.11% | Buy |
| WNS | WNS | $57.50 | $87.17 | 51.60% | Buy |
| ASGN | ASGN | $92.72 | $99.00 | 6.77% | Hold |
| G | Genpact | $39.29 | $41.67 | 6.06% | Hold |
| CACI | CACI | $476.24 | $447.50 | -6.03% | Buy |
| SAIC | Science Applications | $136.62 | $123.50 | -9.60% | Buy |
| LDOS | Leidos | $155.50 | $136.22 | -12.40% | Buy |
| IT | Gartner | $510.56 | $434.89 | -14.82% | Hold |
| PSN | Parsons | $98.22 | $82.83 | -15.67% | Buy |
| EXLS | ExlService | $36.38 | $28.30 | -22.21% | Buy |
CLVT Forecast FAQ
Is Clarivate a good buy?
Yes, according to 3 Wall Street analysts, Clarivate (CLVT) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 1 'Buy' recommendations, accounting for 33.33% of CLVT's total ratings.
What is CLVT's price target?
Clarivate (CLVT) average price target is $14.33 with a range of $11 to $20, implying a 118.11% from its last price of $6.57. The data is based on 3 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Clarivate stock go up soon?
According to Wall Street analysts' prediction for CLVT stock, the company can go up by 118.11% (from the last price of $6.57 to the average price target of $14.33), up by 204.41% based on the highest stock price target, and up by 67.43% based on the lowest stock price target.
Can Clarivate stock reach $10?
CLVT's average twelve months analyst stock price target of $14.33 supports the claim that Clarivate can reach $10 in the near future.
What are Clarivate's analysts' financial forecasts?
Clarivate's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $2.71B (high $2.75B, low $2.7B), average EBITDA is $1.05B (high $1.07B, low $1.05B), average net income is $582.76M (high $592.35M, low $577.84M), average SG&A $875.9M (high $886.99M, low $870.21M), and average EPS is $0.85 (high $0.864, low $0.843). CLVT's analysts financial forecasts for the fiscal year (Dec 2027) are as follows: average revenue is $2.82B (high $2.86B, low $2.8B), average EBITDA is $1.1B (high $1.11B, low $1.09B), average net income is $665.03M (high $676.08M, low $658.83M), average SG&A $910.93M (high $922.56M, low $904.43M), and average EPS is $0.97 (high $0.986, low $0.961).
Did the CLVT's actual financial results beat the analysts' financial forecasts?
Based on Clarivate's last annual report (Dec 2023), the company's revenue was $2.63B, beating the average analysts forecast of $2.61B by 0.65%. Apple's EBITDA was $-85.9M, missing the average prediction of $1.18B by -107.26%. The company's net income was $-987M, missing the average estimation of $456.21M by -316.26%. Apple's SG&A was $739.7M, missing the average forecast of $846.44M by -12.61%. Lastly, the company's EPS was $-1.47, missing the average prediction of $0.741 by -298.44%. In terms of the last quarterly report (Dec 2023), Clarivate's revenue was $683.7M, missing the average analysts' forecast of $684.59M by -0.13%. The company's EBITDA was $-625M, missing the average prediction of $266.03M by -334.94%. Clarivate's net income was $-863M, missing the average estimation of $144.45M by -697.44%. The company's SG&A was $180.4M, missing the average forecast of $221.04M by -18.39%. Lastly, the company's EPS was $-1.3, missing the average prediction of $0.211 by -717.02%